167 related articles for article (PubMed ID: 36594111)
1. Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma.
Wang YT; Chang IC; Chen CY; Hsia JY; Lin FC; Chao WR; Ke TY; Chen YT; Chen CJ; Hsieh MS; Huang SF
Thorac Cancer; 2023 Feb; 14(6):592-601. PubMed ID: 36594111
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the effect of spread through air spaces on postoperative recurrence-free survival in patients with stage pT1N0M0 lung adenocarcinoma of different tumor size].
Zeng H; Tan FW; Yuan ZL; Ren JY; Xu JX; Xue Q
Zhonghua Yi Xue Za Zhi; 2022 May; 102(19):1430-1436. PubMed ID: 35599407
[No Abstract] [Full Text] [Related]
3. Clinical implications of the American Joint Committee on Cancer (AJCC) 8th edition update in seminoma pT1 subclassification.
Fontes-Sousa M; Lobo J; Magalhães H; Cassis J; Malheiro M; Ramos S; Henrique R; Martins A; Maurício MJ
BMC Urol; 2020 Aug; 20(1):127. PubMed ID: 32819326
[TBL] [Abstract][Full Text] [Related]
4. Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma.
Kameda K; Eguchi T; Lu S; Qu Y; Tan KS; Kadota K; Adusumilli PS; Travis WD
J Thorac Oncol; 2018 Dec; 13(12):1919-1929. PubMed ID: 30195703
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
[TBL] [Abstract][Full Text] [Related]
7. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
8. Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma.
Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
J Thorac Oncol; 2019 Feb; 14(2):245-254. PubMed ID: 30336325
[TBL] [Abstract][Full Text] [Related]
9. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.
Yoshizawa A; Motoi N; Riely GJ; Sima CS; Gerald WL; Kris MG; Park BJ; Rusch VW; Travis WD
Mod Pathol; 2011 May; 24(5):653-64. PubMed ID: 21252858
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience.
Wilshire CL; Louie BE; Horton MP; Castiglioni M; Aye RW; Farivar AS; West HL; Gorden JA; Vallières E
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1561-8. PubMed ID: 26897242
[TBL] [Abstract][Full Text] [Related]
11. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications.
Ito M; Miyata Y; Kushitani K; Yoshiya T; Mimae T; Ibuki Y; Misumi K; Takeshima Y; Okada M
Lung Cancer; 2014 Aug; 85(2):270-5. PubMed ID: 24976332
[TBL] [Abstract][Full Text] [Related]
12. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
14. Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2021 Jul; 12(13):1952-1958. PubMed ID: 34037324
[TBL] [Abstract][Full Text] [Related]
15. Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists.
Lobo J; Costa AL; Vilela-Salgueiro B; Rodrigues Â; Guimarães R; Cantante M; Lopes P; Antunes L; Jerónimo C; Henrique R
Hum Pathol; 2018 Dec; 82():113-124. PubMed ID: 30041024
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the AJCC Eighth-Edition Prognostic Staging System for Breast Cancer in a Latin American Cohort.
Cervera-Bonilla S; Rodríguez-Ossa P; Vallejo-Ortega M; Osorio-Ruiz A; Mendoza-Diaz S; Orozco-Ospino M; Lehmann-Mosquera C; Duarte-Torres C; Ángel-Aristizábal J; Guzmán-Abisaab L; Garcia-Mora M; Diaz-Casas S
Ann Surg Oncol; 2021 Oct; 28(11):6014-6021. PubMed ID: 33830356
[TBL] [Abstract][Full Text] [Related]
17. External Validation of AJCC Eighth Edition of Non-small-cell Lung Cancer Staging Among African Americans.
Uprety D; Borgert AJ; Fitzsimmons AJ; Parsons BM
Clin Lung Cancer; 2021 May; 22(3):e371-e378. PubMed ID: 32713769
[TBL] [Abstract][Full Text] [Related]
18. Validation of the eighth edition of the American Joint Committee on Cancer staging system and proposal of an improved staging system for pancreatic ductal adenocarcinoma.
Park MY; Shin SH; Song KB; Hwang D; Lee JH; Lee YJ; Kim SC
Ann Hepatobiliary Pancreat Surg; 2019 Feb; 23(1):46-55. PubMed ID: 30863807
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of cancer-associated active fibroblasts and invasive architectural patterns on early-stage lung adenocarcinoma.
Yotsukura M; Asamura H; Suzuki S; Asakura K; Yoshida Y; Nakagawa K; Sakurai H; Watanabe SI; Motoi N
Lung Cancer; 2020 Jul; 145():158-166. PubMed ID: 32450494
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2021 Jul; 12(14):2072-2077. PubMed ID: 34033216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]